LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $761,643 | +65.4% | 12,711 | +99.0% | 0.01% | +100.0% |
| Q2 2023 | $460,431 | +879.6% | 6,386 | +1319.1% | 0.00% | – |
| Q4 2019 | $47,000 | -19.0% | 450 | -22.1% | 0.00% | -100.0% |
| Q3 2019 | $58,000 | +56.8% | 578 | +80.6% | 0.00% | – |
| Q2 2019 | $37,000 | -2.6% | 320 | +6.7% | 0.00% | – |
| Q1 2019 | $38,000 | -97.7% | 300 | -97.5% | 0.00% | -100.0% |
| Q4 2018 | $1,628,000 | +16180.0% | 12,000 | +17042.9% | 0.02% | – |
| Q4 2017 | $10,000 | +25.0% | 70 | +12.9% | 0.00% | – |
| Q3 2017 | $8,000 | – | 62 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |